Merck Constructs FLEx Center in Rahway

Merck began construction in January of 2019 on a $300 million pharmaceutical formulation and process development facility in Rahway, N.J. Designed for maximum flexibility, the Formulation Laboratory Experimental (FLEx) Center will feature modular cleanrooms and cGMP manufacturing suites to support multiple modalities including large and small molecule, sterile, and oral solid-dosage products. Open-plan laboratory spaces will house mobile casework and overhead service carriers, and a robust IT infrastructure will leverage digital technologies to create integrated workflows. The facility will enable diversified product lines to be manufactured on a smaller scale to support the development of personalized medicine solutions. Jacobs is providing architectural and engineering services for the project, which is slated for completion in early 2021.